Budesonide Suspension
Product Images NDC 50090-6590

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 50090-6590). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906590)

Budesonide Inhalation Suspension 0.25 mg/2 mL label from A-S Medication Solutions. The label includes usage instructions indicating it contains 2 mL ampules delivering 200 mcg per dose for respiratory inhalation. It mentions storage conditions and packaging details with lot and NDC numbers.*

FDA Label Image

Spl-budesonide-fig-1 (Spl Budesonide Fig 1)

A line graph depicting nighttime asthma symptom changes from baseline over a 12-week period in pediatric patients not previously on inhaled corticosteroid therapy. The graph compares mean changes for placebo and three dosage levels of Budesonide suspension (.25 mg, .5 mg, and 1 mg once daily), showing symptom improvement trends across multiple time intervals.*

FDA Label Image

Spl-budesonide-fig-2 (Spl Budesonide Fig 2)

A line chart titled 'Nighttime Asthma Change from Baseline' from a 12-week trial in pediatric patients previously maintained on inhaled corticosteroid therapy. The graph plots mean change in nighttime asthma symptoms from baseline over weeks, comparing three groups: placebo, Budesonide 0.25 mg twice daily, and Budesonide 0.5 mg twice daily. P-values for 0.25 mg and 0.5 mg doses are 0.022 and 0.021, respectively.*

FDA Label Image

Spl-budesonide-fig-3 (Spl Budesonide Fig 3)

A line graph titled 'Nighttime Asthma Change from Baseline' from a 12-week trial in pediatric patients using Budesonide or placebo. The y-axis shows mean change from baseline nighttime asthma symptoms, and the x-axis represents time intervals from baseline up to 12 weeks. Multiple lines compare placebo and various Budesonide dosing regimens (0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily, and 0.5 mg twice daily) showing symptom changes over time.*

FDA Label Image

Spl-budesonide-fig-4 (Spl Budesonide Fig 4)

An illustration showing two hands holding five single-use ampules arranged side by side. Each ampule is labeled sterile and marked 'For oral inhalation only', featuring fields for lot number and expiration date. The ampule tops are connected in a strip, with 'SUN PHARMA' printed on each tab.*

FDA Label Image

Spl-budesonide-fig-5 (Spl Budesonide Fig 5)

An instructional illustration showing a hand holding a sterile single-dose vial labeled for oral inhalation only. The image depicts the step of removing or flipping off the vial's protective tab as indicated by a curved arrow pointing downward and right.*

FDA Label Image

Spl-budesonide-fig-6 (Spl Budesonide Fig 6)

An instructional illustration showing how to twist and open a unit dose ampule of Budesonide oral inhalation suspension. One hand holds the ampule while the other hand grips the top tab, indicated by an arrow showing the twisting direction to open. The label on the ampule partially reads 'For oral inhalation only.'*

FDA Label Image

Spl-budesonide-fig-7 (Spl Budesonide Fig 7)

An instructional line drawing showing the use of a respiratory inhalation suspension. One hand holds a small vial labeled 'STERILE For oral inhalation only' and a drop is falling from the vial into a breathable cup device held by the other hand.*

FDA Label Image

Spl-budesonide-str (Spl Budesonide Str)

Chemical structure of Budesonide, the active ingredient in the respiratory inhalation suspension by A-S Medication Solutions, shown with rings, hydroxyl groups, and various carbon and hydrogen atoms in a steroid backbone configuration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.